Jonathan P. Galeotti

Medical Genetics

1926 Good Hope Rd
Enola, PA 17025

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Mutational profiling of HIV+ diffuse large B-cell lymphoma reveals distinct mutational features with evidence of genomic instability.

Mutational profiling of HIV+ diffuse large B-cell lymphoma reveals distinct mutational features with evidence of genomic instability.

Journal: AIDS (London, England)

Published: September 23, 2025

Transformation of an abnormal karyotype to acute erythroid leukemia in a pediatric patient with Fanconi anemia: A case report.

Transformation of an abnormal karyotype to acute erythroid leukemia in a pediatric patient with Fanconi anemia: A case report.

Journal: Pediatric blood & cancer

Published: March 20, 2024

HIV and prior exposure to antiretroviral therapy alter tumour composition and tumour: T-cell associations in diffuse large B-cell lymphoma.

HIV and prior exposure to antiretroviral therapy alter tumour composition and tumour: T-cell associations in diffuse large B-cell lymphoma.

Journal: British journal of haematology

Published: March 06, 2024

HIV infection and ART exposure affect tumor TCR repertoire of diffuse large B cell lymphoma.

HIV infection and ART exposure affect tumor TCR repertoire of diffuse large B cell lymphoma.

Journal: JCI insight

Published: March 05, 2024

Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms.

Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms.

Journal: Leukemia & lymphoma

Published: November 03, 2023

Multiple lineage switches in KMT2A rearranged infant leukemia, responsive to combination therapy with CPX-351 and inotuzumab.

Multiple lineage switches in KMT2A rearranged infant leukemia, responsive to combination therapy with CPX-351 and inotuzumab.

Journal: Pediatric blood & cancer

Published: August 04, 2023

A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.

A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.

Journal: Blood cancer journal

Published: March 29, 2023

Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia.

Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia.

Journal: Journal of cellular and molecular medicine

Published: July 08, 2022

Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after enasidenib treatment.

Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after enasidenib treatment.

Journal: Leukemia & lymphoma

Published: June 21, 2021

Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutations.

Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutations.

Journal: Blood advances

Published: May 18, 2021

The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.

The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.

Journal: BMC cancer

Published: March 18, 2021

Myeloid neoplasms in the setting of chronic lymphocytic leukaemia/chronic lymphocytic leukaemia-like disease: a clinicopathological study of 66 cases comparing cases with prior history of treatment to those without.

Myeloid neoplasms in the setting of chronic lymphocytic leukaemia/chronic lymphocytic leukaemia-like disease: a clinicopathological study of 66 cases comparing cases with prior history of treatment to those without.

Journal: Journal of clinical pathology

Published: December 10, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026